142 related articles for article (PubMed ID: 3793386)
1. An in vitro assay for evaluating chemosensitivity of leukaemia cells: preclinical studies.
Menconi E; Lepri E; Bonmassar E; Frati L; Barzi A
Int J Tissue React; 1986; 8(6):485-92. PubMed ID: 3793386
[TBL] [Abstract][Full Text] [Related]
2. [A short term test suitable for in vitro prediction of the drug sensitivity of human leukemias: a preliminary study on murine experimental neoplasms].
Menconi E; Lepri E; Barzi AM
Boll Soc Ital Biol Sper; 1984 Feb; 60(2):413-9. PubMed ID: 6712803
[TBL] [Abstract][Full Text] [Related]
3. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
Lepri E; Menconi E; Barzi AM
Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
6. Effect of platinum(II) choline complex on murine leukemias L1210 and P388.
Ochocki J; Glinka R; Cieśliński M; Góra-Tybor J; Potemski P
Pharmazie; 1997 Jul; 52(7):567-9. PubMed ID: 9266598
[No Abstract] [Full Text] [Related]
7. Effect of 2,3-dihydro-1 H-imidazo[1,2-b]pyrazole on the proliferation of mouse leukemic and normal cells in vivo.
Ganapathi R; Krishan A
Cancer Res; 1980 Apr; 40(4):1103-8. PubMed ID: 7357541
[TBL] [Abstract][Full Text] [Related]
8. Some new aryl-sydnones: effects on murine tumours.
Grynberg N; Gomes R; Shinzato T; Echevarria A; Miller J
Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
Macquet JP; Cros S; Armand JP
Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
[TBL] [Abstract][Full Text] [Related]
10. Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.
Rauko P; Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Schott H; Fritzer-Szekeres M; Novotny L; Szekeres T
Anticancer Res; 2003; 23(5A):3841-6. PubMed ID: 14666686
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic activity of 1-(3-oxoprop-1-enyl)-2-pyridones.
Ho LK; Knaus EE; Allen TM; Fathi-Afshar R
Drug Des Deliv; 1988 Feb; 2(3):227-37. PubMed ID: 3255317
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
13. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
14. In vitro chemosensitivity testing of human tumours by collagen gel droplet culture and image analysis.
Tanigawa N; Kitaoka A; Yamakawa M; Tanisaka K; Kobayashi H
Anticancer Res; 1996; 16(4A):1925-30. PubMed ID: 8712722
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin cytotoxicity to P388 lymphocytic leukemia as determined by alkaline elution and established assays.
Russo P; Favoni RE; Zarcone D; Miglietta L; Peluso M; Nicolin A; Bignone F; Parodi S
Anticancer Res; 1986; 6(6):1297-304. PubMed ID: 3813486
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of the antitumor action of spirobromine in mice with leukemia P-388].
Sokolova IS; Riabokon' NA; Chernov VA; Gorbacheva LB
Izv Akad Nauk SSSR Biol; 1989; (5):660-5. PubMed ID: 2584530
[TBL] [Abstract][Full Text] [Related]
17. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
Gutsche W; Schulze W; Jungstand W; Wohlrabe K
Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
[TBL] [Abstract][Full Text] [Related]
18. A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
Atassi G; Dumont P; Kabbe HJ; Yoder O
Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319
[TBL] [Abstract][Full Text] [Related]
19. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.
Trafalis DT; Tsavdaridis D; Camoutsis C; Karayiani V; Mourelatos D; Dalezis P; Athanassiou A; Pangalis GA; Papageorgiou A
Br J Haematol; 2005 Feb; 128(3):343-50. PubMed ID: 15667536
[TBL] [Abstract][Full Text] [Related]
20. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
